Banerjee Subhashis sold $16K of ARTV
Banerjee Subhashis (Chief Medical Officer) sold 4,037 shares of Artiva Biotherapeutics, Inc. (ARTV) at $3.91 on 2026-11-17.
How this was made
The 30-second read
Why it matters
The filing provides transparency on insider selling activity by the Chief Medical Officer, but it does not include any new clinical, regulatory, or financial guidance.
Market read
Traders may note the insider sale for sentiment, but the transaction value is small and does not constitute a fundamental catalyst.
What to watch
Insider sales can be driven by diversification, taxes, or personal liquidity needs; without additional context, traders should avoid extrapolating to business performance.
Background
The article is an SEC Form 4 insider transaction disclosure for Artiva Biotherapeutics, Inc.
Ticker impact
Artiva Biotherapeutics CMO Banerjee Subhashis sold 4,037 shares in an open-market transaction for about $15.8k, per a fresh SEC Form 4.
Likely limited downside pressure or no reaction as the transaction size is small and lacks a stated catalyst.
The filing is a primary SEC Form 4 disclosure, but the dollar value (~$15.8k) is modest and does not indicate a company-specific operational or financial change.
Market effects
Minimal, as the disclosure is company-specific insider activity with no sector-wide signal.
None expected.
None expected.
Counterpoint
The absence of a cited 10b5-1 plan could be interpreted as discretionary selling, but the small size makes it unlikely to be information-bearing.
Key entities
- issuerArtiva Biotherapeutics, Inc.
US-listed biotech subject of the Form 4 insider sale disclosure.
- insiderBanerjee Subhashis
Chief Medical Officer who sold shares in an open-market transaction.



